- Patent Title: Native microfluidic CE-MS analysis of antibody charge heterogeneity
-
Application No.: US16777230Application Date: 2020-01-30
-
Publication No.: US12169203B2Publication Date: 2024-12-17
- Inventor: Hongxia Wang , Haibo Qiu , Ning Li
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Kramer Levin Naftalis & Frankel LLP
- Main IPC: G01N33/68
- IPC: G01N33/68 ; G01N1/40

Abstract:
Methods for detecting and/or discriminating between post-translational modification variants of an antibody of interest in a sample. The methods including: contacting a sample comprising one or more antibodies of interest with a protease to digest the sample into antibody fragments; separating antibody fragments by molecular weight and/or charge in one or more capillaries using capillary electrophoresis; eluting separated antibody fragments from the one or more capillaries; and determining the mass of the eluted antibody fragments by mass spec analysis, thereby detecting and/or discriminating between post-translational modification variants of the antibody of interest.
Public/Granted literature
- US20200249241A1 Native Microfluidic CE-MS Analysis of Antibody Charge Heterogeneity Public/Granted day:2020-08-06
Information query
IPC分类: